APOGEE ENTERPRISES ($APOG) posted quarterly earnings results for Q4 2026 on Friday, April 24th. The company reported earnings of $0.92 per share, beating estimates of $0.89 by $0.03. The company also reported revenue of $351,350,000, beating estimates of $342,533,003 by $8,816,997.
You can see Quiver Quantitative's $APOG stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
APOGEE ENTERPRISES Hedge Fund Activity
We have seen 100 institutional investors add shares of APOGEE ENTERPRISES stock to their portfolio, and 121 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VICTORY CAPITAL MANAGEMENT INC removed 1,079,196 shares (-88.4%) from their portfolio in Q4 2025, for an estimated $39,293,526
- DEPRINCE RACE & ZOLLO INC added 351,923 shares (+70.3%) to their portfolio in Q4 2025, for an estimated $12,813,516
- MILLENNIUM MANAGEMENT LLC removed 298,359 shares (-71.6%) from their portfolio in Q4 2025, for an estimated $10,863,251
- FEDERATED HERMES, INC. added 191,783 shares (+524.3%) to their portfolio in Q4 2025, for an estimated $6,982,819
- VANGUARD GROUP INC added 166,402 shares (+6.8%) to their portfolio in Q4 2025, for an estimated $6,058,696
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 148,721 shares (-78.8%) from their portfolio in Q4 2025, for an estimated $5,414,931
- TRUEMARK INVESTMENTS, LLC removed 145,389 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,293,613
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
APOGEE ENTERPRISES Analyst Ratings
Wall Street analysts have issued reports on $APOG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- DA Davidson issued a "Buy" rating on 11/17/2025
To track analyst ratings and price targets for APOGEE ENTERPRISES, check out Quiver Quantitative's $APOG forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
